| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.1 | 0.04 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | 0.074 | 0.04 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.04 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.05 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | 0.36 | 0.05 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.068 | 0.05 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.05 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.13 | 0.05 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.11 | 0.05 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.07 | 0.05 |